finding,pubmed_id,finding_id
"Hinokinin, a lignan isolated from Smilax species, exhibits significant anticancer activity against several human cancer cell lines, including breast (MCF-7, MDA-MB-231), lung (A549), colon (HCT-116), prostate (DU145), and leukemia (HL-60, K562), with IC50 values ranging from 2.3 to 56.2 μg/mL.",PMC6271885,PMC6271885_0
"Hinokinin has been shown to possess significant antioxidant activity, with IC50 values ranging from 1.2 to 10.4 μg/mL in the DPPH, ABTS, and FRAP assays.",PMC6271885,PMC6271885_1
"Hinokinin exhibits significant anti-inflammatory activity, with IC50 values ranging from 3.4 to 34.4 μg/mL in the NO assay, and with IC50 values ranging from 1.3 to 34.6 μg/mL in the COX-2 inhibition assay.",PMC6271885,PMC6271885_2
"Hinokinin demonstrates significant antimicrobial activity, with MIC values ranging from 0.38 to 7.8 μg/mL against oral pathogens, such as Enterococcus faecalis, Candida albicans, and Streptococcus species.",PMC6271885,PMC6271885_3
"Hinokinin has been shown to be non-genotoxic and to possess neuroprotective effects against glutamate-induced neurotoxicity in primary cultures of rat cortical cells, with protection percentages of 33.2% and 42.6%, respectively, at 1.0 μg/mL and 10.0 μg/mL concentrations.",PMC6271885,PMC6271885_4
